We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNL
6876
CALL
DELISTED
Knoll, Inc.
KNL
$2K ﹤0.01%
+100
New +$2.26K
SGB
6877
DELISTED
Southwest Georgia Financial Corporation
SGB
$2K ﹤0.01%
+75
New +$1.7K
OSIR
6878
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$2K ﹤0.01%
+147
New +$1.47K
RNWK
6879
DELISTED
RealNetworks Inc
RNWK
$2K ﹤0.01%
742
+542
+271% +$1.82K
ADAP
6880
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
58
-35,053
-100% -$367K
AGRO icon
6881
Adecoagro
AGRO
$1.36B
$1K ﹤0.01%
+125
New +$1.01K
AIRG icon
6882
Airgain
AIRG
$72.4M
$1K ﹤0.01%
44
AIRT icon
6883
Air T
AIRT
$86.1M
$1K ﹤0.01%
+54
New +$1.2K
APT icon
6884
Alpha Pro Tech
APT
$53.1M
$1K ﹤0.01%
389
+365
+1,521% +$1.28K
ARCT icon
6885
Arcturus Therapeutics
ARCT
$211M
$1K ﹤0.01%
84
AVDL
6886
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
221
-800
-78% -$4.32K
AWRE icon
6887
Aware
AWRE
$27.7M
$1K ﹤0.01%
216
+144
+200% +$539
BOXL icon
6888
Boxlight
BOXL
$2.13M
0
CBAN icon
6889
Colony Bankcorp
CBAN
$467M
$1K ﹤0.01%
+35
New +$618
CIBR icon
6890
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.3B
$1K ﹤0.01%
42
CLMB icon
6891
Climb Global Solutions
CLMB
$519M
$1K ﹤0.01%
+408
New +$1.31K
PRHI
6892
Presurance Holdings
PRHI
$17.2M
$1K ﹤0.01%
+25
New +$1.09K
COHN icon
6893
Cohen & Co
COHN
$36.4M
$1K ﹤0.01%
+57
New +$568
CRBP icon
6894
Corbus Pharmaceuticals
CRBP
$190M
$1K ﹤0.01%
5
-358
-99% -$57.9K
CRF
6895
Cornerstone Total Return Fund
CRF
$1.17B
$1K ﹤0.01%
77
+20
+35% +$275
CSPI icon
6896
CSP Inc
CSPI
$82.1M
$1K ﹤0.01%
+108
New +$634
CVR icon
6897
Chicago Rivet & Machine Co
CVR
$10.3M
$1K ﹤0.01%
+22
New +$698
DES icon
6898
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$1K ﹤0.01%
26
-26
-50% -$782
DIT icon
6899
AMCON Distributing
DIT
$1K ﹤0.01%
+11
New +$626
ERNA icon
6900
Eterna Therapeutics
ERNA
$4.91M
0

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.